TGFβ-PDL1 signaling in neutrophils preserves lung barrier during hyperinflammation
Abstract
The hyperinflammatory syndromes in critically ill patients, including trauma, sepsis, and acute lung injury, are characterized by dysregulated neutrophil responses that contribute to tissue damage and poor outcomes. Using murine models of cytokine storm induced by trauma and lung injury, we identified transforming growth factor β (TGFβ) as a central regulator of immune checkpoint in neutrophils. TGFβ signaling modulates neutrophil activation and upregulates the expression of programmed death-ligand 1 (PDL1). Disruption of TGFβ signaling during hyperinflammation restores the migratory capacity of neutrophils but leads to excessive activation, severe pulmonary tissue damage, and increased susceptibility to spontaneous bacterial infection in the lung. Mechanistically, PDL1 expression alters neutrophil behavior within lung capillaries, promoting intravascular clustering and restricting tissue infiltration. Targeted deletion of PDL1 in neutrophils reverses hyperinflammation-induced clustering, restores effective trafficking to infectious foci, and enhances host-protective immune function while limiting pathological neutrophil hyperactivation. These findings define a TGFβ-PDL1 regulatory axis that restrains the pathogenicity of neutrophils during hyperinflammation, revealing a checkpoint mechanism that balances host defense and tissue integrity.
Article Details
Authors (24)
Ziyi Li
Andrew Reese Moore
Stanford University, Stanford, California, United States
Hong Zheng
Center of Nanomaterials for Renewable Energy, State Key Laboratory of Electrical Insulation and Power Equipment, School of Electrical Engineering
Janmes Karunamurthy
McGill University, Montreal, Quebec, Canada
Aanya Bhagrath
McGill University, Montreal, Quebec, Canada
Jiangxue Li
Daniel Young
Leonardo F. Jurado
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Katalina Couto
McGill University, Montreal, Quebec, Canada
Amelia Kulle
McGill University, Montreal, Quebec, Canada
Haley Park
McGill University, Montreal, Quebec, Canada
Ashley Kwak
McGill University Health Centre, Montreal, Quebec, Canada
Vaishnav Belur
McGill University, Pierrefonds, Quebec, Canada
Sebastien Talbot
Maziar Divangahi
McGill University, Montreal, QC, Canada
Antonio DiGiandomenico
AstraZeneca, Gaithersburg, Maryland, United States
Angela Rogers
Taylor S Cohen
AstraZeneca, Gaithersburg, Maryland, United States
Allen Joseph Ehrlicher
McGill University, Montreal, PQ, Canada
Judith N. Mandl
McGill University, Montreal, Quebec, Canada
Jing Wang
Hunan Cancer Hospital Changsha China
Antoine Dufour
Purvesh Khatri
Department of Microbiology and Immunology, Stanford University School of Medicine
Ajitha Thanabalasuriar
McGill University, Montreal, Quebec, Canada